FDAnews Drug Daily Bulletin

CFR Pharmaceuticals Jumps After IM Trust Raises Target Price

Feb. 6, 2013
A A
CFR Pharmaceuticals had the biggest gain in almost a month after brokerage firm IM Trust raised its target price on the stock and said an acquisition last year may boost sales.
BusinessWeek